Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ: BNGO )

5.760 +0.230 (+4.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Which stocks are experiencing notable movement on Monday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
These stocks are moving in today's session
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Outlook For Bionano Genomics
Via Benzinga
Earnings Outlook For Bionano Genomics
Via Benzinga
How Is The Market Feeling About Bionano Genomics?
Via Benzinga
Bionano Genomics: Q3 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript
BNGO earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript
BNGO earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
A Preview Of Bionano Genomics's Earnings
Via Benzinga
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Quantum AI Stocks That Could Redefine Computing
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Sorry Healthcare Stocks to Sell in May While You Still Can
Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell. 
Via InvestorPlace
The 3 Best Healthcare Stocks to Buy in May 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now. 
Via InvestorPlace
BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Contrarian Investments to Make Now for Massive Upside Potential
A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive. 
Via InvestorPlace
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
These excellent contrarian stock picks are well-positioned to benefit from huge trends and are likely to be very profitable for investors. 
Via InvestorPlace
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
3 Stocks That Are Poised to Generate Outsized Returns
The Street is greatly underestimating the potential of these three names, making them wonderful stocks to buy for big returns. 
Via InvestorPlace
Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript
BNGO earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Deeply Undervalued Growth Stocks
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks. 
Via InvestorPlace
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.